Novavax (NVAX) Asset Utilization Ratio (2011 - 2026)

Novavax's Asset Utilization Ratio history runs 16 years deep, the most recent figure standing at 0.48 for Q1 2026.

• On a quarterly basis, Asset Utilization Ratio fell 45.5% year-over-year to 0.48 in Q1 2026; TTM through Mar 2026 was 0.48, a 45.5% decrease from a year earlier, with the FY2025 full-year figure at 0.82, up 102.06% from the prior year.
• Asset Utilization Ratio slipped to 0.48 in Q1 2026 per NVAX's latest filing, from 0.9 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.99 in Q2 2023 and bottomed at 0.42 in Q4 2024.
• The 5-year median for Asset Utilization Ratio is 0.63 (2024), against an average of 0.68.
• Across the five-year window, Asset Utilization Ratio surged 115.67% in 2025 and slumped 45.5% in 2026, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.88 in 2022, then slumped by 34.97% to 0.57 in 2023, then slipped by 26.8% to 0.42 in 2024, then soared by 115.67% to 0.9 in 2025, then sank by 46.67% to 0.48 in 2026.
• Per Business Quant, the three latest NVAX Asset Utilization Ratio figures stand at 0.48 (Q1 2026), 0.9 (Q4 2025), and 0.8 (Q3 2025).